JP2008531467A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531467A5 JP2008531467A5 JP2007541462A JP2007541462A JP2008531467A5 JP 2008531467 A5 JP2008531467 A5 JP 2008531467A5 JP 2007541462 A JP2007541462 A JP 2007541462A JP 2007541462 A JP2007541462 A JP 2007541462A JP 2008531467 A5 JP2008531467 A5 JP 2008531467A5
- Authority
- JP
- Japan
- Prior art keywords
- glucocorticosteroid
- suspension
- sterile
- heating
- liquid excipient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003862 glucocorticoid Substances 0.000 claims 21
- 238000000034 method Methods 0.000 claims 21
- 239000000725 suspension Substances 0.000 claims 17
- 238000010438 heat treatment Methods 0.000 claims 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims 8
- 239000007788 liquid Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 239000004094 surface-active agent Substances 0.000 claims 3
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 230000000172 allergic effect Effects 0.000 claims 2
- 239000007900 aqueous suspension Substances 0.000 claims 2
- 229940092705 beclomethasone Drugs 0.000 claims 2
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 claims 2
- 229960004436 budesonide Drugs 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000008223 sterile water Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 claims 1
- 229960003728 ciclesonide Drugs 0.000 claims 1
- 229960003469 flumetasone Drugs 0.000 claims 1
- WXURHACBFYSXBI-GQKYHHCASA-N flumethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O WXURHACBFYSXBI-GQKYHHCASA-N 0.000 claims 1
- 229960000676 flunisolide Drugs 0.000 claims 1
- 229940043075 fluocinolone Drugs 0.000 claims 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 claims 1
- 229960002714 fluticasone Drugs 0.000 claims 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 claims 1
- 239000007951 isotonicity adjuster Substances 0.000 claims 1
- 229960001664 mometasone Drugs 0.000 claims 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 claims 1
- 230000003134 recirculating effect Effects 0.000 claims 1
- 229950004432 rofleponide Drugs 0.000 claims 1
- IXTCZMJQGGONPY-XJAYAHQCSA-N rofleponide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O IXTCZMJQGGONPY-XJAYAHQCSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 229960005294 triamcinolone Drugs 0.000 claims 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims 1
- 239000000080 wetting agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0425266.4 | 2004-11-16 | ||
| GB0425266A GB0425266D0 (en) | 2004-11-16 | 2004-11-16 | Pharmaceutical manufacturing process |
| PCT/US2005/041524 WO2006055632A2 (en) | 2004-11-16 | 2005-11-16 | Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008531467A JP2008531467A (ja) | 2008-08-14 |
| JP2008531467A5 true JP2008531467A5 (https=) | 2008-12-11 |
| JP5116478B2 JP5116478B2 (ja) | 2013-01-09 |
Family
ID=33523819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007541462A Expired - Lifetime JP5116478B2 (ja) | 2004-11-16 | 2005-11-16 | 医薬製造法 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8178519B2 (https=) |
| EP (1) | EP1833462B1 (https=) |
| JP (1) | JP5116478B2 (https=) |
| KR (1) | KR101226856B1 (https=) |
| CN (2) | CN101068531B (https=) |
| AU (1) | AU2005307825C1 (https=) |
| CA (1) | CA2587393C (https=) |
| CY (1) | CY1114150T1 (https=) |
| DK (1) | DK1833462T3 (https=) |
| ES (1) | ES2409713T3 (https=) |
| GB (1) | GB0425266D0 (https=) |
| IL (2) | IL183082A (https=) |
| PL (1) | PL1833462T3 (https=) |
| PT (1) | PT1833462E (https=) |
| SI (1) | SI1833462T1 (https=) |
| WO (1) | WO2006055632A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
| US10987361B2 (en) | 2010-02-08 | 2021-04-27 | Shenzhen Evergreen Therapeutics Co., Ltd. | Treating auto-immune and auto-inflammatory diseases |
| US10993879B2 (en) * | 2010-02-08 | 2021-05-04 | Shenzhen Evergreen Therapeutics Co., Ltd. | Pulmonary delivery of progestogen |
| EP3689364A1 (en) | 2010-02-08 | 2020-08-05 | Shenzhen Evergreen Therapeutics Co., Ltd. | Methods for the use of progestogen as a glucocorticoid sensitizer |
| WO2011139479A2 (en) | 2010-04-30 | 2011-11-10 | H R D Corporation | High shear application in drug delivery |
| US8888736B2 (en) | 2010-04-30 | 2014-11-18 | H R D Corporation | High shear application in medical therapy |
| IN2014CH01890A (https=) * | 2014-04-10 | 2015-10-16 | Aurobindo Pharma Ltd | |
| JP6521351B2 (ja) * | 2014-10-14 | 2019-05-29 | テックプロジェクトサービス株式会社 | ウィルス不活化およびサンプリング装置 |
| JP6719459B2 (ja) | 2014-10-29 | 2020-07-08 | アール.ピー.シェーラー テクノロジーズ、エルエルシー | 逆成形同時充填パッケージング |
| CN104739811A (zh) * | 2015-02-27 | 2015-07-01 | 上海臣邦医药科技有限公司 | 一种糖皮质激素雾化吸入混悬液及其制备方法 |
| EP3386483A4 (en) * | 2015-12-07 | 2019-06-05 | Emcure Pharmaceuticals Limited | STERILE PARENTERAL SUSPENSIONS |
| CN106904723A (zh) * | 2017-02-24 | 2017-06-30 | 东华大学 | 利用过氧化钙氧化去除水中糖皮质激素的方法 |
| WO2021230342A1 (ja) * | 2020-05-15 | 2021-11-18 | 大日本印刷株式会社 | 無菌充填機の洗浄・殺菌方法及び無菌充填機 |
| WO2022098321A1 (en) * | 2020-11-09 | 2022-05-12 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Process for the preparation of sterilised suspensions for the administration by inhalation |
| CN112891328A (zh) * | 2021-04-12 | 2021-06-04 | 上海方予健康医药科技有限公司 | 一种吸入用布地奈德混悬液的制备方法 |
| WO2022231533A1 (en) * | 2021-04-29 | 2022-11-03 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Process for the preparation of sterilized suspensions for the inhalation by nebulization |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3962430A (en) * | 1974-08-07 | 1976-06-08 | Merck & Co., Inc. | Sterilization of solid non-electrolyte medicinal agents employing sodium chloride |
| DE4026978A1 (de) * | 1990-08-25 | 1992-02-27 | Bayer Ag | Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung |
| GB9410222D0 (en) | 1994-05-21 | 1994-07-06 | Glaxo Wellcome Australia Ltd | Medicaments |
| SE9704186D0 (sv) | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
| US6066292A (en) * | 1997-12-19 | 2000-05-23 | Bayer Corporation | Sterilization process for pharmaceutical suspensions |
| EP0938896A1 (en) | 1998-01-15 | 1999-09-01 | Novartis AG | Autoclavable pharmaceutical compositions containing a chelating agent |
| IT1303692B1 (it) * | 1998-11-03 | 2001-02-23 | Chiesi Farma Spa | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
| EP1074369B1 (fr) * | 1999-08-04 | 2005-10-05 | Conception et Développement Michelin S.A. | Procédé de fabrication de pièces en composite fortement sollicitées |
| JP4516165B2 (ja) * | 1999-08-04 | 2010-08-04 | 株式会社ユポ・コーポレーション | 多層樹脂延伸フィルム |
| KR100657729B1 (ko) * | 1999-10-21 | 2006-12-13 | 신닛테츠가가쿠 가부시키가이샤 | 적층체 및 그의 제조방법 |
| JP3862924B2 (ja) * | 2000-03-27 | 2006-12-27 | 日東電工株式会社 | 光学フィルム積層体 |
| DE60132446T2 (de) * | 2000-03-28 | 2009-01-15 | The Board Of Regents Of Oklahoma State University, Stillwater | Anordnung selbsttragender filme mittels eines schichtweisen verfahrens |
| DE60143892D1 (de) * | 2000-07-21 | 2011-03-03 | Cellseed Ind | Herzmuskel-ähnliche zellschicht, dreidimensionales konstrukt, herzmuskel-ähnliches gewebe und verfahren zur herstellung |
| BR0115584A (pt) * | 2000-11-24 | 2003-09-23 | Breath Ltd | Esterilização de produtos farmacêuticos |
| US20040022862A1 (en) * | 2000-12-22 | 2004-02-05 | Kipp James E. | Method for preparing small particles |
| US6541309B2 (en) * | 2001-03-21 | 2003-04-01 | Hewlett-Packard Development Company Lp | Fabricating a molecular electronic device having a protective barrier layer |
| DE10145361A1 (de) * | 2001-09-14 | 2003-04-03 | Pari Gmbh | Verfahren zur Herstellung von flüssigen, sterilen Zubereitungen zur Inhalation |
| ITMI20020808A1 (it) | 2002-04-17 | 2003-10-17 | Chiesi Farma Spa | Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione |
| EP1454636A1 (en) * | 2003-03-04 | 2004-09-08 | Dompé S.P.A. | Sterilization of glucocorticoid drug particles for pulmonary delivery |
| GB0410995D0 (en) * | 2004-05-17 | 2004-06-23 | Norton Healthcare Ltd | Heat sterilization of glucocorticosteroids |
-
2004
- 2004-11-16 GB GB0425266A patent/GB0425266D0/en not_active Ceased
-
2005
- 2005-11-16 CN CN2005800415649A patent/CN101068531B/zh not_active Expired - Lifetime
- 2005-11-16 AU AU2005307825A patent/AU2005307825C1/en not_active Expired
- 2005-11-16 US US11/667,872 patent/US8178519B2/en active Active
- 2005-11-16 CA CA2587393A patent/CA2587393C/en not_active Expired - Lifetime
- 2005-11-16 DK DK05851715.2T patent/DK1833462T3/da active
- 2005-11-16 ES ES05851715T patent/ES2409713T3/es not_active Expired - Lifetime
- 2005-11-16 SI SI200531722T patent/SI1833462T1/sl unknown
- 2005-11-16 EP EP05851715.2A patent/EP1833462B1/en not_active Expired - Lifetime
- 2005-11-16 PT PT58517152T patent/PT1833462E/pt unknown
- 2005-11-16 CN CN2011102299122A patent/CN102327211A/zh active Pending
- 2005-11-16 JP JP2007541462A patent/JP5116478B2/ja not_active Expired - Lifetime
- 2005-11-16 WO PCT/US2005/041524 patent/WO2006055632A2/en not_active Ceased
- 2005-11-16 KR KR1020077011131A patent/KR101226856B1/ko not_active Expired - Lifetime
- 2005-11-16 PL PL05851715T patent/PL1833462T3/pl unknown
-
2007
- 2007-05-09 IL IL183082A patent/IL183082A/en active IP Right Grant
-
2012
- 2012-04-16 US US13/447,468 patent/US20120258939A1/en not_active Abandoned
-
2013
- 2013-05-16 CY CY20131100393T patent/CY1114150T1/el unknown
- 2013-10-03 IL IL228730A patent/IL228730A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008531467A5 (https=) | ||
| US20120258939A1 (en) | Pharmaceutical manufacturing process | |
| JP5001657B2 (ja) | 噴霧化用のシクレソニドの水性懸濁液 | |
| CA2652573A1 (en) | Unit dose formulations comprising an inhalable solution of albuterol | |
| CA2481520A1 (en) | Process for preparation of a sterile suspension of corticosteroid particles for administration by inhalation | |
| JP2025506543A (ja) | エンシフェントリンを含む無菌液体医薬組成物の滅菌プロセス | |
| JP2007538089A5 (https=) | ||
| CN111821261B (zh) | 用于制备无菌眼用水性丙酸氟替卡松a型纳米晶体混悬液的方法 | |
| CN1988886B (zh) | 糖皮质激素的热力灭菌法 | |
| JP4457422B2 (ja) | 点鼻組成物 | |
| ES2974900T3 (es) | Formulación de suspensión mejorada de un corticoesteroide para administración por medio de inhalación | |
| ES2388287T3 (es) | Procedimiento para la preparación de suspensiones concentradas de fármacos y kit correspondiente | |
| AU2018318123B2 (en) | Aqueous nebulization composition | |
| WO1999034776A1 (en) | Nasal drop compositions | |
| TR2023013885T2 (tr) | Nebuli̇zasyon yoluyla i̇nhalasyon i̇çi̇n steri̇li̇ze edi̇lmi̇ş süspansi̇yonlarin hazirlanmasi yöntemi̇ | |
| US20150290220A1 (en) | Pharmaceutical formualtions comprising a Gluococorticosteroid | |
| AU2012200155A1 (en) | Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions | |
| WO2022231533A1 (en) | Process for the preparation of sterilized suspensions for the inhalation by nebulization | |
| HK1166689A (en) | Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions |